Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANGIODYNAMICS INCANGO · Entity 5275 | Director | July 18, 2018 | July 21, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANGIODYNAMICS INC
Report date July 18, 2018 · Filed July 21, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,484 |
Reported balance
After 2018-07-18 transaction · row 1
1 source rowRow 1 · 2018-07-18 · Grant · Acquired 6,307 · Balance 48,484 F1: The acquisition of 6,307 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 6,307 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/18/2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The acquisition of 6,307 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 6,307 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/18/2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 18, 2018 Filed Jul 21, 2018 01:27 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 6,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-033085 · doc1.xml · nonDerivative · entry 1 LaPorte Steve · CIK 0001340404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,484 F1 · shares: The acquisition of 6,307 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 6,307 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/18/2019. Read SEC document |
| July 26, 2017 Filed Jul 28, 2017 19:39 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 7,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-029112 · doc1.xml · nonDerivative · entry 1 LaPorte Steve · CIK 0001340404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,177 F1 · shares: The acquisition of 7,976 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 7,976 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/26/2018. Read SEC document |
| January 13, 2017 Filed Jan 17, 2017 19:34 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $15.75 | $0.00 |
DisclosureSEC source: 0001140361-17-002000 · doc1.xml · derivative · entry 3 LaPorte Steve · CIK 0001340404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires 2017-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options became exercisable as to 4,667 shares on August 3, 2011, 4,667 shares on August 3, 2012 and 4,666 shares on August 3, 2013. Read SEC document |
| January 13, 2017 Filed Jan 17, 2017 19:34 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Tax withholdingCommon Stock | 14,000 | $17.92 | $250,880.00 |
DisclosureSEC source: 0001140361-17-002000 · doc1.xml · nonDerivative · entry 2 LaPorte Steve · CIK 0001340404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,201 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.89 to $17.99, inclusive. The options exercised to purchase the shares were granted on 8/3/2010 and were set to expire on 8/3/2017. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1. Read SEC document |
| January 13, 2017 Filed Jan 17, 2017 19:34 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionCommon Stock | 14,000 | $15.75 | $220,500.00 |
DisclosureSEC source: 0001140361-17-002000 · doc1.xml · nonDerivative · entry 1 LaPorte Steve · CIK 0001340404 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.